GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Finds Gender Disparities in Substance Use Disorder Treatment Outcomes Linked to Social Determinants of Health

by GOAI
Share To

A recent study conducted by researchers Chavez, Peltier, and McKee examines how social determinants of health influence treatment outcomes for individuals with substance use disorders, with a particular focus on differences between men and women. The research highlights notable disparities in treatment success rates based on gender, shedding light on an often-overlooked aspect of healthcare. The study explores the intersection of sex-based differences and external factors such as socioeconomic status, access to care, and support systems in shaping recovery outcomes.

The findings suggest that social determinants of health play a significant role in influencing the effectiveness of substance use disorder treatments. Researchers observed distinct variations between men and women in terms of how these factors impact recovery. While the study does not draw specific conclusions about causation, it emphasizes the importance of considering gender-specific needs when designing treatment programs. This research adds to a growing body of work aimed at understanding how biological and social factors intersect to affect health outcomes across different populations.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top